Every morning, millions of people around the world swallow a multivitamin. We do it because we believe it will keep us healthier, protect our hearts, sharpen our brains, and maybe even help us live longer. But after decades of research and billions of dollars in sales, what does the science actually say?
A massive new “rapid review” published in Ageing Research Reviews (one of the leading journals on aging science) has synthesized 19 high-quality meta-analyses covering more than 5.5 million people – including over 333,000 pregnancies and 904,000 children. The findings are both encouraging and sobering.
The short answer? Multivitamins work for some things, for some people, but they are not a magic pill for everyone. And they definitely do not help you live longer.
The Headline: No Effect on Mortality
Let’s get the most important finding out of the way first. A meta-analysis of 21 randomized controlled trials (91,074 adults, average age 62 years, average follow-up 43 months) found no effect of multivitamin use on all-cause mortality.
Whether you took a multivitamin or a placebo, your risk of dying during the study period was essentially the same (RR = 0.98; 95% CI: 0.94–1.02). There was also no benefit for death from vascular causes or cancer.
Takeaway: If you are taking a multivitamin hoping to live longer, the evidence says it will not help.
The Good News: Real Benefits for Specific Groups
But here is where the story gets more interesting – and encouraging. While multivitamins do not prevent death, they do provide measurable benefits for specific health outcomes in specific populations.
Table 1: Where Multivitamins Show Real Benefits (RCT Evidence)
| Health Outcome | Population | Effect Size | What It Means |
|---|---|---|---|
| Global cognition & episodic memory | Adults ≥60 years without dementia | MD = 0.07 (cognition); MD = 0.06 (memory) | Equivalent to reducing cognitive aging by ~2 years |
| Immediate free recall | Cognitively intact adults (18+ years) | SMD = 0.32 | Better short-term memory |
| Stress, anxiety, fatigue | Healthy adults (18–65 years) | SMD = 0.35 (stress); 0.32 (anxiety); 0.27 (fatigue) | Significant reduction in psychological symptoms |
| Systolic blood pressure | Adults with hypertension or chronic disease | -1.31 mmHg (SBP); hypertensive subgroup: -7.98 mmHg | Small but real blood pressure reduction |
| Infections | Younger adults (<65 years), undernourished or hospitalized | WMD = -1.20 infections | Fewer infections in at-risk younger adults |
SMD = standardized mean difference; MD = mean difference; WMD = weighted mean difference. All findings statistically significant.
The Brain Benefits: Real and Measurable
Two meta-analyses found convincing evidence that multivitamins benefit cognitive function in older adults. The COSMOS trial substudy (5,203 adults aged 60+ without dementia) found that daily multivitamin use for 2-3 years significantly improved global cognition and episodic memory – with an effect size equivalent to reducing cognitive aging by approximately two years.
Another meta-analysis of 10 RCTs (3,200 adults) found that multivitamin supplementation significantly improved immediate free recall memory – the ability to remember information right after learning it.
Why this matters: As populations age worldwide, any safe, affordable intervention that slows cognitive decline by even two years could have enormous public health implications.
The Psychological Benefits: Less Stress, Less Anxiety
A meta-analysis of 8 RCTs (1,292 healthy adults) found that multivitamin supplementation significantly reduced:
- Perceived stress (SMD = 0.35)
- Mild psychiatric symptoms (SMD = 0.30)
- Anxiety (SMD = 0.32)
- Fatigue (SMD = 0.27)
- Confusion (SMD = 0.23)
The effects were stronger for supplements containing high doses of B vitamins compared to broader-range, lower-dose formulations. For healthy adults under significant stress, this is encouraging news.
The Blood Pressure Benefit: Small but Real
A meta-analysis of 12 RCTs (23,207 adults) found that multivitamin supplementation reduced systolic blood pressure by a small but significant amount (-1.31 mmHg). However, subgroup analysis revealed something more important: the effect was much larger in people who actually needed it.
- In hypertensive individuals: -7.98 mmHg SBP
- In people with chronic diseases (diabetes, cardiovascular conditions): -6.29 mmHg SBP
- In healthy normotensive individuals: minimal effect
Takeaway: Multivitamins do not prevent hypertension, but they may help lower blood pressure in people who already have high blood pressure or chronic disease.
The Observational Findings: Associations Worth Noting
While randomized controlled trials are the gold standard for proving causation, observational studies (which follow people over time) can identify associations that may be real. The review found several encouraging associations from high-quality observational studies:
- Colorectal cancer: 8% lower risk (RR = 0.92) among multivitamin users
- Coronary heart disease: 12% lower risk (RR = 0.88) – though RCTs did not confirm this
- Cataracts: 27-34% lower risk for nuclear cataracts (both observational and RCT evidence)
- Fragility hip fractures: 51% lower risk (OR = 0.49)
Table 2: Observational Associations (Not Proof of Causation)
| Outcome | Risk Reduction | Study Type | Caveat |
|---|---|---|---|
| Colorectal cancer | 8% | Cohort studies | Association only |
| Coronary heart disease | 12% | Cohort studies | Not confirmed by RCTs |
| Nuclear cataracts | 27-34% | Cohort + RCT | Consistent evidence |
| Fragility hip fractures | 51% | Observational | Needs RCT confirmation |
Pregnancy Benefits: Real Protection for Children
One of the most encouraging findings involved multivitamin use during pregnancy. Observational studies found that maternal multivitamin supplementation was associated with:
- Lower risk of pediatric cancers: Leukemia (36% lower), brain tumors (27% lower), neuroblastoma (47% lower)
- Lower risk of neural tube defects: 33% lower (RR = 0.67)
- Lower risk of small-for-gestational-age births: 23% lower (RR = 0.77)
While these are observational findings (not proof of causation), the consistency and strength of the associations are striking. For pregnant women, prenatal vitamins are already standard care – this review reinforces their value beyond just folic acid.
The Warnings: Where Multivitamins May Harm
Not all findings were positive. One meta-analysis found that multivitamin supplementation increased the risk of age-related macular degeneration progression by more than twofold (RR = 2.08). This finding is based on high-quality RCT evidence and should give pause to older adults with early macular degeneration.
Also, the review found no benefits for:
- Breast cancer or prostate cancer prevention
- Stroke incidence or mortality
- COVID-19 outcomes (ICU admission, hospital stay, mortality)
- Visual acuity
- Preterm birth, low birth weight, or stillbirth
Why the Confusion? The Problem with “Multivitamin”
One of the most important findings of this review is not about health outcomes at all – it is about methodology. The authors note that there is no universally accepted standard for what constitutes a multivitamin. Different products contain different ingredients, different doses, and different forms of vitamins and minerals.
When a meta-analysis pools studies using completely different products, the results may be diluted or distorted. This “definitional ambiguity” is a major limitation of the entire field.
The “Healthy User Effect”: A Persistent Bias
The review also highlights a well-known bias in supplement research: the “healthy user effect.” People who take multivitamins tend to be healthier overall – they exercise more, smoke less, eat better, and have better access to healthcare. This can make multivitamins look more beneficial than they actually are in observational studies.
However, the authors note that this bias cuts both ways. RCTs may recruit participants who are healthier and better nourished than the general population – precisely the people least likely to benefit from supplementation. The real benefits of multivitamins may be larger in people with marginal deficiencies or higher baseline disease risk.
The Bottom Line: Personalized Nutrition, Not One-Size-Fits-All
The review concludes with a clear recommendation: shift from generalized supplementation to personalized nutritional strategies.
Multivitamins are not a waste of money for everyone. They provide real, measurable benefits for:
- Older adults seeking to preserve cognitive function
- Stressed, healthy adults (especially with B vitamins)
- People with hypertension or chronic disease (for blood pressure)
- Younger, undernourished adults (for infection reduction)
- Pregnant women (for pediatric cancer and neural tube defect prevention)
But they do not prevent death, do not prevent most cancers, and may even harm in the case of macular degeneration.
The takeaway for the average person: Do not assume a daily multivitamin is a substitute for a healthy diet. But for specific populations and specific health goals, the evidence supports targeted use. Talk to your doctor. Get your nutrient levels tested if possible. And remember: no pill can replace vegetables, exercise, and sleep.
Reference: here
Other Articles: